cannabis indica

Câncer — Cérebro

termo de indexação original: Cancer - Brain

O acervo do Cannabis Indica reúne 98 estudos científicos que tocam a condição Câncer — Cérebro, publicados entre 1992 e 2023. Pela leitura automatizada, 85 (87%) foram classificados como favoráveis, 10 (10%) como inconclusivos e 3 (3%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é estudo laboratorial (42 estudos), seguido de metanálise (31). Os compostos mais presentes são Endocanabinoide (não especificado), Tetraidrocanabinol (THC) e Canabinoides Sintéticos WIN-x. Aparece com frequência ao lado de Câncer, Câncer — Mama e Câncer — Pulmão.

Estudos indexados
98
Período coberto
1992–2023
Favoráveis
85 · 87%
Inconclusivos
10 · 10%
Desfavoráveis
3 · 3%
Termo original
Cancer - Brain

O acervo em números

Tipo de estudo

Estudo Laboratorial42
Metanálise31
Estudo em Animais16
Ensaio Clínico6
Metanálise Clínica2
Ensaio Clínico Duplo-Cego1

Direção do resultado

Favorável85
Inconclusivo10
Desfavorável3

Por década

1990s5
2000s13
2010s38
2020s42

98 estudos

Filtrar e buscar no acervo →
  1. 2023

    Cannabidiol-induced crosstalk of apoptosis and macroautophagy in colorectal cancer cells involves p53 and Hsp70

    FavorávelEstudo LaboratorialCâncerEstresse OxidativoCâncer — Pulmão+2
  2. 2023

    Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma

  3. 2023

    Could cannabinoids provide a new hope for ovarian cancer patients?

  4. 2022

    Biological effects of cannabidiol on human cancer cells: Systematic review of the literature

  5. 2022

    Biophysical Studies and In Vitro Effects of Tumor Cell Lines of Cannabidiol and Its Cyclodextrin Inclusion Complexes

    FavorávelEstudo LaboratorialDorCâncerNáusea e VômitoTetraidrocanabinol (THC)+3
  6. 2022

    Borneol and Tetrandrine Modulate the Blood-Brain Barrier and Blood-Tumor Barrier to Improve the Therapeutic Efficacy of 5-Fluorouracil in Brain Metastasis

    FavorávelEstudo em AnimaisCâncer
  7. 2022

    Cannabinoids as anticancer drugs: current status of preclinical research

  8. 2022

    Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis

  9. 2022

    Cannabis Biomolecule Effects on Cancer Cells and Cancer Stem Cells: Cytotoxic, Anti-Proliferative, and Anti-Migratory Activities

    FavorávelMetanáliseCâncerEndocanabinoide (não especificado)
  10. 2022

    Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature

    FavorávelMetanáliseDorCâncerAnsiedadeTetraidrocanabinol (THC)THC Farmacêutico+17
  11. 2022

    Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist

  12. 2022

    Endocannabinoid signaling in glioma

  13. 2022

    Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions

  14. 2022

    In Silico Binding Analysis of Cannabinoids with Eph Receptors for Therapeutic Use in Gliomas

    FavorávelEstudo LaboratorialCâncerCanabicromeno (CBC)Canabidivarina (CBDV)
  15. 2022

    Interaction of Glia Cells with Glioblastoma and Melanoma Cells under the Influence of Phytocannabinoids

  16. 2022

    Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?

  17. 2022

    The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling

    FavorávelEstudo LaboratorialCâncerCanabigerol (CBG)
  18. 2022

    The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling

  19. 2022

    The Role of Nutritional Status, Gastrointestinal Peptides, and Endocannabinoids in the Prognosis and Treatment of Children with Cancer

    InconclusivoMetanáliseDorCâncerObesidadeAnandamida (AEA)Tetraidrocanabinol (THC)+17
  20. 2022

    Therapeutic Potential of Cannabinoids on Tumor Microenvironment: A Molecular Switch in Neoplasia Transformation

  21. 2021

    A cannabidiol-loaded Mg-gallate metal-organic framework-based potential therapeutic for glioblastomas

    FavorávelEstudo LaboratorialCâncer
  22. 2021

    A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma

    FavorávelEnsaio Clínico Duplo-CegoCâncerTHC:CBD Farmacêutico
  23. 2021

    A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas

    FavorávelEnsaio ClínicoCâncer
  24. 2021

    Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma

    FavorávelEstudo em AnimaisCâncerTetraidrocanabinol (THC)
  25. 2021

    Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?

    FavorávelMetanáliseCâncerCâncer — MamaCâncer — Pulmão+1
  26. 2021

    Cannabidiol converts NFκB into a tumor suppressor in glioblastoma with defined antioxidative properties

    FavorávelEstudo LaboratorialCâncer
  27. 2021

    Cannabidiol Induces Apoptosis and Perturbs Mitochondrial Function in Human and Canine Glioma Cells

    FavorávelEstudo LaboratorialCâncerAplicações Veterinárias
  28. 2021

    Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4

    FavorávelEstudo em AnimaisCâncer
  29. 2021

    Cannabidiol Treatment Results in a Common Gene Expression Response Across Aggressive Cancer Cells from Various Origins

    FavorávelEstudo LaboratorialCâncerCâncer — MamaCâncer — Metastático+2
  30. 2021

    Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma

    FavorávelEstudo LaboratorialCâncerCanabigerol (CBG)
  31. 2021

    Cannabinoids in glioblastoma multiforme-hype or hope?

    FavorávelMetanáliseCâncer
  32. 2021

    Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor Microenvironment

    FavorávelEstudo em AnimaisCâncer
  33. 2021

    Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro

    FavorávelEstudo LaboratorialCâncerCanabinoides Sintéticos AM-xCanabinoides Sintéticos SR-x+3
  34. 2021

    Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in TP53 or PTEN Tumor Suppressors

    FavorávelEstudo LaboratorialCâncerCanabinoides Sintéticos WIN-xCanabinoides Sintéticos JWH-x
  35. 2021

    Tea tree oil extract causes mitochondrial superoxide production and apoptosis as an anticancer agent, promoting tumor infiltrating neutrophils cytotoxic for breast cancer to induce tumor regression

    FavorávelEstudo LaboratorialCâncerEstresse OxidativoCâncer — MamaOutros Compostos Relacionados+6
  36. 2021

    THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner

    FavorávelEstudo LaboratorialCâncerAnandamida (AEA)Endocanabinoide (não especificado)
  37. 2021

    The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology

    InconclusivoMetanáliseCâncerCâncer — LeucemiaCâncer — Neuroblastoma+1
  38. 2021

    Treatment options for progression or recurrence of glioblastoma: a network meta-analysis

    InconclusivoMetanálise ClínicaCâncer
  39. 2020

    Borneol promotes apoptosis of Human Glioma Cells through regulating HIF-1a expression via mTORC1/eIF4E pathway

    FavorávelEstudo em AnimaisCâncer
  40. 2020

    Cannabinoid Signaling in Glioma Cells

    FavorávelMetanáliseCâncerEndocanabinoide (não especificado)
  41. 2020

    Enhanced Anti-Glioma Efficacy by Borneol Combined With CGKRK-Modified Paclitaxel Self-Assembled Redox-Sensitive Nanoparticles

    FavorávelEstudo LaboratorialCâncer
  42. 2020

    Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway

    FavorávelEstudo LaboratorialCâncer
  43. 2019

    Concomitant Treatment of Malignant Brain Tumours With CBD - A Case Series and Review of the Literature

    FavorávelEnsaio ClínicoCâncer
  44. 2019

    Pep-1&borneol-Bifunctionalized Carmustine-Loaded Micelles Enhance Anti-Glioma Efficacy Through Tumor-Targeting and BBB-Penetrating

    FavorávelEstudo LaboratorialCâncer
  45. 2019

    Potential role of cannabidiol for seizure control in a patient with recurrent glioma.

    FavorávelMetanáliseCâncerEpilepsia
  46. 2019

    Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers

  47. 2019

    Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling

    FavorávelEstudo LaboratorialCâncerCâncer — Mama
  48. 2019

    The Endocannabinoid System of Animals

  49. 2018

    Cannabis Therapeutics and the Future of Neurology

  50. 2018

    Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol

    FavorávelMetanáliseCâncer
  51. 2018

    Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development

    FavorávelMetanáliseCâncer
  52. 2018

    Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage

    FavorávelEstudo LaboratorialCâncer
  53. 2018

    Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma

    FavorávelEstudo em AnimaisCâncerTHC:CBD Farmacêutico
  54. 2018

    Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol

  55. 2018

    Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide

    FavorávelEstudo em AnimaisCâncer
  56. 2017

    Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and Endocannabinoid System in Two Human Cancer Lines

    FavorávelEstudo LaboratorialCâncerCâncer — MamaÔmega-3Ômega-6
  57. 2017

    Quantitative Analyses Of Synergistic Responses Between Cannabidiol And DNA-damaging Agents On The Proliferation And Viability Of Glioblastoma And Neural Progenitor Cells In Culture

    FavorávelEstudo LaboratorialCâncer
  58. 2017

    Regulation Of Human Glioblastoma Cell Death By Combined Treatment Of Cannabidiol, γ-radiation And Small Molecule Inhibitors Of Cell Signaling Pathways

    FavorávelEstudo LaboratorialCâncerSíndrome Aguda da Radiação
  59. 2016

    Dihydroceramide Accumulation Mediates Cytotoxic Autophagy Of Cancer Cells Via Autolysosome Destabilization

    FavorávelEstudo em AnimaisCâncerTetraidrocanabinol (THC)
  60. 2016

    Spontaneous Involution Of Pediatric Low-grade Gliomas: High Expression Of Cannabinoid Receptor 1 (CNR1) At The Time Of Diagnosis May Indicate Involvement Of The Endocannabinoid System

    FavorávelEstudo LaboratorialCâncerEndocanabinoide (não especificado)
  61. 2015

    Cannabidiol Stimulates Aml-1a-dependent Glial Differentiation And Inhibits Glioma Stem-like Cells Proliferation By Inducing Autophagy In A TRPV2-dependent Manner

    FavorávelEstudo LaboratorialCâncer
  62. 2015

    Cytotoxicity of Endogenous Lipids N-acyl Dopamines and Their Possible Metabolic Derivatives for Human Cancer Cell Lines of Different Histological Origin

  63. 2015

    Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells.

    FavorávelEstudo LaboratorialCâncer
  64. 2015

    On The Effects Of CP 55-940 And Other Cannabinoid Receptor Agonists In C6 And U373 Cell Lines

    FavorávelEstudo LaboratorialCâncerAnandamida (AEA)Canabinoides Sintéticos WIN-x+1
  65. 2015

    Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.

    FavorávelMetanáliseCâncer
  66. 2015

    The Antitumor Action Of Cannabinoids On Glioma Tumorigenesis

    FavorávelMetanáliseCâncerEndocanabinoide (não especificado)
  67. 2014

    Cannabinoid Signaling In Glioma Cells

  68. 2014

    Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas.

    FavorávelMetanáliseCâncer
  69. 2014

    The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model

    FavorávelEstudo em AnimaisCâncerTetraidrocanabinol (THC)
  70. 2013

    Anticancer and antioxidant properties of terpinolene in rat brain cells

    FavorávelEstudo LaboratorialCâncer
  71. 2013

    Critical Appraisal Of The Potential Use Of Cannabinoids In Cancer Management

  72. 2013

    Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents.

    FavorávelEstudo LaboratorialCâncer
  73. 2012

    Cannabidiol As Potential Anticancer Drug

  74. 2012

    Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas

    FavorávelEstudo em AnimaisCâncer
  75. 2011

    A Combined Preclinical Therapy Of Cannabinoids And Temozolomide Against Glioma

    FavorávelEstudo em AnimaisCâncerTetraidrocanabinol (THC)Canabinoides Sintéticos SR-x
  76. 2011

    Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.

    FavorávelEnsaio ClínicoCâncer
  77. 2011

    Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55

  78. 2011

    Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas--possible role of Cannabis inhalation.

    FavorávelMetanáliseCâncer
  79. 2010

    Cannabidiol Enhances The Inhibitory Effects Of Delta9-tetrahydrocannabinol On Human Glioblastoma Cell Proliferation And Survival

    FavorávelEstudo em AnimaisCâncerTetraidrocanabinol (THC)
  80. 2010

    Opposite Changes In Cannabinoid CB1 And CB2 Receptor Expression In Human Gliomas

    FavorávelEstudo LaboratorialCâncerCanabinoides Sintéticos WIN-x
  81. 2008

    Delta 9-tetrahydrocannabinol Inhibits Cell Cycle Progression By Downregulation Of E2F1 In Human Glioblastoma Multiforme Cells

    FavorávelEstudo LaboratorialCâncer
  82. 2008

    Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.

    FavorávelEnsaio ClínicoCâncer
  83. 2007

    Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis

  84. 2007

    Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?

    FavorávelEstudo em AnimaisCâncerTetraidrocanabinol (THC)Canabinoides Sintéticos JWH-x
  85. 2007

    HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor

  86. 2006

    A Pilot Clinical Study Of Delta9-tetrahydrocannabinol In Patients With Recurrent Glioblastoma Multiforme

    FavorávelEnsaio ClínicoCâncer
  87. 2006

    The Non-psychoactive Cannabidiol Triggers Caspase Activation And Oxidative Stress In Human Glioma Cells

    FavorávelEstudo LaboratorialCâncer
  88. 2006

    The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells

  89. 2005

    Cannabidiol Inhibits Human Glioma Cell Migration Through A Cannabinoid Receptor-independent Mechanism

    FavorávelEstudo LaboratorialCâncerCanabinoides Sintéticos SR-x
  90. 2005

    Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells.

    FavorávelEstudo LaboratorialCâncerTetraidrocanabinol (THC)Canabinoides Sintéticos WIN-x
  91. 2004

    Antitumor Effects Of Cannabidiol, A Nonpsychoactive Cannabinoid, On Human Glioma Cell Lines

    FavorávelEstudo em AnimaisCâncer
  92. 2004

    Cannabinoids Inhibit The Vascular Endothelial Growth Factor Pathway In Gliomas

    FavorávelEnsaio ClínicoCâncerAnandamida (AEA)Tetraidrocanabinol (THC)+3
  93. 2001

    Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor

    FavorávelEstudo em AnimaisCâncerCanabinoides Sintéticos SR-xCanabinoides Sintéticos JWH-x
  94. 1998

    Δ9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells

    FavorávelEstudo LaboratorialCâncerCanabinoides Sintéticos SR-x
  95. 1997

    Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol).

    FavorávelMetanáliseDorCâncerNáusea e VômitoTHC Farmacêutico+8
  96. 1996

    2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells

    InconclusivoEstudo LaboratorialCâncerCâncer — Neuroblastoma
  97. 1996

    Determination of the cannabinoid receptors in mouse x rat hybridoma NG108-15 cells and rat GH4C1 cells

  98. 1992

    Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.

    InconclusivoEstudo LaboratorialCâncerCâncer — NeuroblastomaCanabinoides Sintéticos WIN-x

Continue por aqui

Perguntas frequentes

Quantos estudos sobre câncer — cérebro estão indexados no acervo?
São 98 estudos, publicados entre 1992 e 2023. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Estudo Laboratorial: 42 · Metanálise: 31 · Estudo em Animais: 16 · Ensaio Clínico: 6 · Metanálise Clínica: 2 · Ensaio Clínico Duplo-Cego: 1. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 85 favoráveis, 10 inconclusivos e 3 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Câncer — Cérebro — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/cancer-cerebro/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Câncer — Cérebro — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/cancer-cerebro/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.